Insulet applies for clearance of next-gen insulin pump; Q1 net loss lessens
This article was originally published in Clinica
Executive Summary
Insulet has filed a 510(k) submission with the US FDA for the next-generation version of its OmniPod insulin management system. Insulet has already applied for permission to CE mark the OmniPod.